FMR LLC 13D and 13G filings for Monte Rosa Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-06 10:03 am Sale | 2025-05-30 | 13G | Monte Rosa Therapeutics, Inc. GLUE | FMR LLC | 1,750,731 2.800% | -3,350,682 (-65.68%) | Filing |
| 2024-11-12 10:32 am Sale | 2024-11-08 | 13G | Monte Rosa Therapeutics, Inc. GLUE | FMR LLC | 5,101,413 8.312% | -435,826 (-7.87%) | Filing |
| 2024-02-09 09:28 am Sale | 2024-02-08 | 13G | Monte Rosa Therapeutics, Inc. GLUE | FMR LLC | 5,537,239 11.056% | -680,219 (-10.94%) | Filing |
| 2023-02-09 12:01 pm Sale | 2023-02-09 | 13G | Monte Rosa Therapeutics, Inc. GLUE | FMR LLC | 6,217,458 12.846% | -758,429 (-10.87%) | Filing |
| 2022-02-09 09:22 am Purchase | 2022-02-08 | 13G | Monte Rosa Therapeutics, Inc. GLUE | FMR LLC | 6,975,887 14.999% | 803,610 (+13.02%) | Filing |
| 2021-08-10 10:33 am Purchase | 2021-08-09 | 13G | Monte Rosa Therapeutics, Inc. GLUE | FMR LLC | 6,172,277 13.873% | 6,172,277 (New Position) | Filing |